XML 25 R25.htm IDEA: XBRL DOCUMENT

The Business (Tables)

9 Months Ended

Sep. 30, 2015

The Business [Abstract]

Subsidiary [Table Text Block]



Entity		Percentage of Ownership		Location
Caladrius Biosciences, Inc.		100%		United States of America
NeoStem Therapies, Inc.		100%		United States of America
Stem Cell Technologies, Inc.		100%		United States of America
Amorcyte, LLC		100%		United States of America
PCT, LLC, a Caladrius Company		100%		United States of America
NeoStem Family Storage, LLC		100%		United States of America
Athelos Corporation (1)		97.0%		United States of America
PCT Allendale, LLC		100%		United States of America
NeoStem Oncology, LLC		100%		United States of America